MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment

MARKET CLOSE: NZ shares rise as vaccine trial boosts global sentiment
Dan Brunskill
New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus. The S&P/NZX 50 Index rose 116.38 points, or 1 percent, to 11,610.52. Within the index, 34 stocks rose and 16 fell. Turnover was $186.9 million. The experimental vaccine, developed by biotech company Moderna, safely induced an immune response against covid-19 in all 45 participants, researchers reported in The New England Journal of Medicine. Moderna has now announced that a phase 3...

More Markets

Softer market ignores Budget
Markets Market Close

Softer market ignores Budget

Post-Budget, all eyes are on the Reserve Bank's OCR announcement next Wednesday.

Jamie Gray 23 May 2025
Restaurant Brands ‘does not seem to care’: Shareholder
Retail

Restaurant Brands ‘does not seem to care’: Shareholder

At the fiery annual meeting, a shareholder called the Californian market a ‘sinkhole’.

Gregor Thompson 23 May 2025
Channel increases dividend, mulls ASX listing
Infrastructure

Channel increases dividend, mulls ASX listing

Dividend up from 11c to between 12c and 12.5c. 

Ian Llewellyn 23 May 2025
Which small cap is off to Aussie? Plus results, and more
Markets The Small Cap Wrap

Which small cap is off to Aussie? Plus results, and more

PaySauce, Blis, Aroa, Foley Wines, John McMahon, and more.